PODD logo

PODD
Insulet Corporation

1,924
Mkt Cap
$15.99B
Volume
546,948.00
52W High
$354.88
52W Low
$216.49
PE Ratio
64.87
PODD Fundamentals
Price
$225.50
Prev Close
$227.08
Open
$225.34
50D MA
$251.83
Beta
0.87
Avg. Volume
1.16M
EPS (Annual)
$3.48
P/B
10.55
Rev/Employee
$501,500.00
$20,718.68
Loading...
Loading...
News
all
press releases
M & L Capital Management Ltd Purchases Shares of 5,630 Insulet Corporation $PODD
M & L Capital Management Ltd acquired a new position in shares of Insulet Corporation (NASDAQ:PODD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Gradient Investments LLC Purchases 10,497 Shares of Insulet Corporation $PODD
Gradient Investments LLC raised its position in shares of Insulet Corporation (NASDAQ:PODD - Free Report) by 17.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·2d ago
News Placeholder
Insulet Corporation $PODD Shares Bought by Nordea Investment Management AB
Nordea Investment Management AB raised its holdings in Insulet Corporation (NASDAQ:PODD - Free Report) by 35.0% in the 4th quarter, according to its most recent 13F filing with the Securities...
MarketBeat·2d ago
News Placeholder
Insulet Corporation $PODD Shares Sold by Swiss Life Asset Management Ltd
Swiss Life Asset Management Ltd lessened its stake in Insulet Corporation (NASDAQ:PODD - Free Report) by 40.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,073 shares of the medical instruments supplier's stock a...
MarketBeat·2d ago
News Placeholder
Hudson Bay Capital Management LP Takes Position in Insulet Corporation $PODD
Hudson Bay Capital Management LP purchased a new stake in Insulet Corporation (NASDAQ:PODD - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 12,504 shares of the medical instruments supplier's stock, valued at approximately...
MarketBeat·3d ago
News Placeholder
Should You Continue to Hold Insulet Stock in Your Portfolio?
PODD's Omnipod 5 momentum and strong growth outlook highlight upside, but macro pressures and rising competition could challenge its near-term performance.
Zacks·4d ago
News Placeholder
Insulet (PODD) Down 8.2% Since Last Earnings Report: Can It Rebound?
Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·4d ago
News Placeholder
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Insulet Corporation (Insulet or the Company) (NASDAQ: PODD) investors...
Business Wire·5d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet...
PR Newswire·5d ago
News Placeholder
Insulet Corporation $PODD Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. lessened its holdings in shares of Insulet Corporation (NASDAQ:PODD - Free Report) by 94.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 278,265 shares of the medical instruments supplier...
MarketBeat·6d ago
<
1
2
...
>

Latest PODD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.